Market Overview

FTC Issues Final Approval for IDEXX Labs Consent Agreement

Share:
Related IDXX
Jim Cramer Gives His Opinion On Starbucks, IDEXX Laboratories And VCA
Canaccord Fireside Chat Takeaways For Abaxis, Heska
Presidential Election Will Not Impact Stocks - Cramer's Mad Money (9/26/16) (Seeking Alpha)

IDEXX Laboratories, Inc. (NASDAQ: IDXX) announced today that the Commissioners of the U.S. Federal Trade Commission ("FTC" or "Commission") have granted final approval of the consent agreement previously reached between the Company and the staff of the FTC Bureau of Competition. The Commission had preliminarily approved the consent agreement in December 2012 and placed the agreement and a proposed draft complaint on public record for comment.

"We are pleased that the Commission has announced final approval of the consent agreement that we reached with the Bureau of Competition staff," said Jonathan Ayers, Chairman and Chief Executive Officer. "While we admit no wrongdoing and continue to believe that our distribution practices did not violate the antitrust laws, this marks final resolution of the multi-year FTC investigation."

Posted-In: News

 

Related Articles (IDXX)

View Comments and Join the Discussion!